Cardiology Centre

Introduction

Our Cardiology Centre is equipped with advanced technology that offers all-round cardiac investigations and treatment. Our professional team offers screening, diagnosis and treatment on cardiac conditions ranging from simple to complex. We listen and offer multidisciplinary approach to formulate a care plan that works for you with the academic achievement of CUHK on clinical practice.

Cardiology Centre

Holter Monitoring

Exercise Stress Test (Treadmill)

Our Services

Screening Procedures:

Electrocardiogram
Exercise Stress (Treadmill) Test

Non-invasive Investigations:

Ambulatory Blood Pressure Monitoring
24-hour ECG (Holter) Monitoring
Cardiac Event Recorder
Tilt Table Test
Transthoracic Echocardiogram
Trans-esophageal Echocardiogram
AI Echocardiogram (AI Echo)
Stress Echocardiogram
DC Cardioversion
Computed Tomography Coronary Angiography

Interventional Procedures:

Coronary Angiogram
Coronary Angiogram and Percutaneous Coronary Intervention
Electrophysical study and Radiofrequency Ablation
Permanent Pacemaker (PPM) Implantation
Leadless Pacemaker Implantation
Bi-Ventricular Pacing for heart failure
Defibrillator (ICD) Implantation
Subcutaneous ICD Implantation
Peripheral Vascular Disease and Intervention
Structural Heart Disease Intervention

Cardiac Services and Fees for Patients with Referral Letter issued by the Hospital Authority

Patients holding a valid referral letter issued by the Hospital Authority can make an appointment at CUHK Medical Centre and receive the following services at the specified fees:

Service items*	Fees (HK$)
Electrocardiogram	$520
Exercise Stress (Treadmill) Test	$2,410
Ambulatory Blood Pressure Monitoring	$1,760
24-hour ECG (Holter) Monitoring	$2,640
Echocardiogram	$2,780

*The above services are non-exhaustive. Please contact the Cardiology Centre for more information.
The original referral letter issued by the Hospital Authority must be presented prior to receiving any of the above services at the specified fees.
The above specified fees are not applicable to inpatient cases.
For enquiries and booking, please contact the Cardiology Centre at 3946 6633.
In the event of any disputes, the decision of CUHK Medical Centre shall be final.

View Consultation Sessions

Milestones

Since the commencement of service in July 2021, CUHKMC Cardiology Center sets out below the key milestones of various debut interventions successfully conducted at CUHKMC’s Cardiac Catherisation Laboratory, and actively engaged in different industry exchange events.

Our Achievements

Date	First Case / Major Operation Conducted
23 JUL 2021	Coronary Angiogram and Percutaneous Coronary Intervention
29 JUL 2021	Permanent Pacemaker Implantation
7 OCT 2021	Electrophysiology Study and Radiofrequency Ablation for a Supraventricular Tachycardia (SVT) case
12 OCT 2021	Atrial Septal Defect Closure
16 NOV 2021	Left Atrial Appendage Occlusion
16 NOV 2021	Electrophysiology Study and Radiofrequency Ablation for an Atrial Fibrillation case
7 DEC 2021	Electrophysiology Study and Cryoballoon Ablation for an Atrial Fibrillation case
25 FEB 2022	Peripheral Angiogram and Lower Limb Angioplasty
12 MAY 2022	Primary Percutaneous Coronary Intervention for an Acute Myocardial Infraction case
13 JUN 2022	Triclip Implantation
13 JUL 2022	Electrophysiology Study and Radiofrequency Ablation for a Premature Ventricular Contraction (PVC) case
18 MAR 2023	1^st Impella Support Complex PCI Case for a Severe Heart Failure Patient
27 APR 2023	Electrophysiology Study and Radiofrequency Ablation for an Atrial Tachycardia case
28 APR 2023	Electrophysiology Study and Radiofrequency Ablation for an Atrial Flutter case
17 MAY 2023	1^st Case under PCI Scheme for Public Hospital Patients
27 MAY 2023	2^nd Impella Support Complex PCI Case for a Triple Vessels Disease with Heavy Calcification case
16 AUG 2023	Implanted Asia first AV2 Micra (leadless pacemaker) case
3 DEC 2023	1^st post arrest primary percutaneous coronary intervention
19 JUN 2024	1^st Electrophysiology Study and Pulsed Field Ablation (PFA) for an Atrial Fibrillation (AF) case Pulsed field ablation releases a series of high-amplitude electrical pulses that last for several microseconds into the target's tissue. Finally, apoptosis is caused to control atrial fibrillation (atrial fibrillation). This technique has been approved by the United States Food and Drug Administration (FDA) for use in patients with persistent or permanent atrial fibrillation. Pulsed field ablation has been introduced in our hospital and has been fully put into service. Pulsed field ablation is easier to perform than other ablations, and it only takes about 3 minutes to complete the isolation of a single pulmonary vein, resulting in a shorter overall operation time. It can help reduce the amount of anesthetic used by patients.
29 MAY 2024	An elderly patient with poor cardiac function suffering from unstable angina and heart failure needed to undergo urgent percutaneous coronary intervention. Cardiology Centre successfully performed the 1^st complex high risk and indicated PCI case in Hong Kong with the support of IVAC 2L, a pulsatile percutaneous ventricular assist device. The patient was hemodynamically stable during the PCI, especially when performing balloon angioplasty to the left main and bifurcation lesions. The patient was discharged home with impairment of cardiac function and symptoms.
29 MAY 2024	First transvenous temporary pacing in a haemodynamically unstable patient
Jul 2024	Two new Intravascular ultrasound (IVUS) Machines are available in cardiology centre. IVUS with AI analytical function, which enables assessment of lesion length and the tightness lesion inside the blood vessels precisely High definition IVUS provides clear ultrasound image to assist PCI procedures.
Aug 2024	Three new shockwave machines are introduced to CUHKMC Cardiology Centre. Shockwave machines are essential equipment to manage heavily calcified coronary artery. With these new shockwave machines, the safety of success rate of complex coronary artery intervention will be further enhanced.
12 Aug 2024	1^st private EKOS for massive pulmonary embolism

International Conference (organised by CUHKMC)

Date	Event
28 MAY 2022	Collaborated with CUHK to organise an international live demonstration educational programme, “Intravascular Imaging and Physiology Guided Percutaneous Coronary Intervention (PCI) Live Case Workshop”, to provide training for both local and international cardiologists.
22 OCT 2022	Kiang Wu Hospital in Macau & CUHK Medical Centre Expert Summit on Percutaneous Coronary Intervention
10 DEC 2022	Live Workshop - Percutaneous Coronary Intervention for Two Cases of Chronic Total Occlusion of the Coronary Arteries

Download

Centre Leaflet

Health Knowledge

View All

Heart HealthHeart Health Videos

All Heart Health Videos

View all videos

Know More

Heart HealthCardiology

健康動脈 VS 動脈狹窄 (Only available in Chinese)

健康的動脈是心臟供血的重要通道，它將氧氣和營養物質從心臟輸送到身體各個組織和器官，維持人體生命。但若心臟動脈出現問題，除可能影響心臟健康，甚至會威脅患者的性命，當中較常見的問題就是動脈狹窄。動脈狹窄是指動脈內壁因某些原因而變窄，導致血液流動受到限制。動脈狹窄可以發生在各種部位的動脈中，最常見的是冠狀動脈。動脈狹窄發生時，因心臟無法得到足夠的氧氣和營養物質，可能會導致心臟功能受損，並引發心臟病相關的症狀，常見的包括胸痛、呼吸困難、心悸、疲勞和頭暈等，嚴重的更可導致心肌梗塞或心臟衰竭等併發症。為了預防及減低動脈狹窄的風險，建立健康的生活方式非常重要，包括：均衡的飲食、定期運動、控制血壓、戒菸和限制酒精攝取等。若有家族病史、高血壓或糖尿病等風險因素，必須定期進行相關檢查，及早診斷和治療以預防嚴重的併發症。

Know More

Heart HealthCardiology

冠狀動脈心臟病治療方法 (Only available in Chinese)

根據患者的病情嚴重程度，冠狀動脈心臟病的治療方法亦有所不同，以下是常用的治療方法：藥物治療藥物治療旨在控制症狀、減少心臟病的病發風險，並改善心臟功能。醫生會根據病者情況作出評估與調整劑量。冠狀動脈介入手術 (通波仔) 冠心病病人很多時沒有明顯症狀，病發時間不能預計，一旦病發或隨時有生命危險，所以手術治療是較為普遍。冠狀動脈介入手術 (通波仔) 是一種常見的血管成形術，能為急性冠心病病人擴張已收窄的冠狀動脈，使血液再流通，減低心臟病的病發及死亡風險。冠狀動脈搭橋手術對於嚴重的冠狀動脈狹窄或多血管病變，冠狀動脈搭橋手術 (CABG) 亦是常見的手術治療方法。手術會在阻塞的動脈位置附近搭建血管繞道，改變血液流通的路線，從而改善心臟的血液及氧氣供應。